A phase 2, randomized, double-blind, placebo-controlled, six-week study of the efficacy and safety of tofimilast dry powder for inhalation in adults with persistent asthma
Latest Information Update: 15 Jun 2012
At a glance
- Drugs Tofimilast (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Pfizer
- 30 Aug 2006 Status change
- 10 Dec 2005 New trial record.